TY - JOUR
T1 - Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder
AU - Shimizu, Yuko
AU - Fujihara, Kazuo
AU - Ohashi, Takashi
AU - Nakashima, Ichiro
AU - Yokoyama, Kazumasa
AU - Ikeguch, Ryotaro
AU - Takahashi, Toshiyuki
AU - Misu, Tatsuro
AU - Shimizu, Satoru
AU - Aoki, Masashi
AU - Kitagawa, Kazuo
N1 - Funding Information:
IN received funding for travel and speaker honoraria from Bayer Schering Pharma and Biogen Idec; and research funding from Mitsubishi Chemical Medience Corporation; as well as Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
Funding Information:
This work was supported by the Ministry of Health, Labor and Welfare of Japan (a Health and Labor Sciences Research Grant on Intractable Diseases; Evidence-based Early Diagnosis and Treatment Strategies for Neuroimmunological Diseases).
Publisher Copyright:
© SAGE Publications.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Background: Few reports describe the influence pregnancy has on the annualized relapse rate (ARR) in neuromyelitis optica spectrum disorder (NMOSD). Objective: To examine pregnancy-related attacks (attacks during pregnancy or within 1 year postpartum) and identify the risk factors for an attack in Japanese NMOSD patients. Methods: We retrospectively reviewed 139 Japanese women whom had aquaporin-4 (AQP4) antibody-positive NMOSD. Among the 114 patients with information, 47 women had 56 pregnancies. We compared the ARR before, during and after pregnancy. Results: Of the 47 NMOSD patients with pregnancy, 22 women (46.8%) had a pregnancy-related attack of the disease (either an onset event or a relapse). The ARR was significantly higher in the first 3 months postpartum (1.80 ± 2.04), than before the pregnancy (0.57 ± 1.16; p = 0.0043) and did not significantly decrease during pregnancy. The ARR before hospitalization and treatment was analyzable in 55 patients without pregnancy and was 1.09 ± 1.17. Among the 11 patients with onset before pregnancy, nine patients had a pregnancy-related attack with a relapse in the previous year, and their immunosuppression was discontinued or made to be at low doses; while the two patients on higher-dose therapies were relapse-free. Conclusion: In the present study, pregnancy-related attack was common in NMOSD, and unlike in multiple sclerosis, the ARR was not reduced during pregnancy. Discontinued or insufficient immunosuppression appeared to increase the risk of pregnancy-related attack.
AB - Background: Few reports describe the influence pregnancy has on the annualized relapse rate (ARR) in neuromyelitis optica spectrum disorder (NMOSD). Objective: To examine pregnancy-related attacks (attacks during pregnancy or within 1 year postpartum) and identify the risk factors for an attack in Japanese NMOSD patients. Methods: We retrospectively reviewed 139 Japanese women whom had aquaporin-4 (AQP4) antibody-positive NMOSD. Among the 114 patients with information, 47 women had 56 pregnancies. We compared the ARR before, during and after pregnancy. Results: Of the 47 NMOSD patients with pregnancy, 22 women (46.8%) had a pregnancy-related attack of the disease (either an onset event or a relapse). The ARR was significantly higher in the first 3 months postpartum (1.80 ± 2.04), than before the pregnancy (0.57 ± 1.16; p = 0.0043) and did not significantly decrease during pregnancy. The ARR before hospitalization and treatment was analyzable in 55 patients without pregnancy and was 1.09 ± 1.17. Among the 11 patients with onset before pregnancy, nine patients had a pregnancy-related attack with a relapse in the previous year, and their immunosuppression was discontinued or made to be at low doses; while the two patients on higher-dose therapies were relapse-free. Conclusion: In the present study, pregnancy-related attack was common in NMOSD, and unlike in multiple sclerosis, the ARR was not reduced during pregnancy. Discontinued or insufficient immunosuppression appeared to increase the risk of pregnancy-related attack.
KW - Anti-aquaporin-4 antibody
KW - immunosuppression
KW - immunosuppressive drugs
KW - neonates
KW - neuromyelitis optica
KW - neuromyelitis optica spectrum disorders
KW - pregnancy
KW - recurrence
KW - relapse rate
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=84989823903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84989823903&partnerID=8YFLogxK
U2 - 10.1177/1352458515583376
DO - 10.1177/1352458515583376
M3 - Article
C2 - 25921053
AN - SCOPUS:84989823903
SN - 1352-4585
VL - 22
SP - 1413
EP - 1420
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
IS - 11
ER -